Drotrecogin alfa (activated): diffusion from clinical trials to clinical practice - Reply

被引：0
|
作者：
Ridley, S. [1 ]
Lwin, A. [2 ]
Wyncoll, D. [3 ]
Lippett, S. [4 ]
Watson, D. [5 ,6 ]
Gunning, K. [7 ]
Higgins, D.
机构：
[1] Glan Clwyd Gen Hosp, Dept Anaesthesia & Intens Care, Rhyl LL18 5UJ, Denbigh, Wales
[2] Norfolk & Norwich Univ Hosp, Dept Acute & Gen Med, Norwich, NY USA
[3] Guys & St Thomas NHS Fdn Trust, Dept Intens Care, London, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Crit Care, London, England
[5] Univ Hosp Coventry, Dept Anaesthesia & Intens Care, Coventry, W Midlands, England
[6] Warwickshire NHS Trust, Warwick, England
[7] Addenbrookes Hosp, Dept Anaesthesia & Intens Care, Cambridge, England
来源：
EUROPEAN JOURNAL OF ANAESTHESIOLOGY | 2008年 / 25卷 / 10期
关键词：
D O I：
10.1017/S0265021508004456
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：862 / 863
页数：2
相关论文
共 50 条
  • [41] From clinical trials to clinical practice - Why the gap?
    Kotchen, Theodore A.
    HYPERTENSION, 2006, 48 (02) : 196 - 197
  • [42] From clinical trials to clinical practice - Bridging the GAP
    Rich, MW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10): : 1321 - 1323
  • [43] From clinical trials to clinical practice in cerebrovascular disease
    Hachinski, V
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 139 - 142
  • [44] The COACH program: From clinical trials to clinical practice
    Vale, MJ
    Jelinek, MV
    Best, JD
    Hoekstra, MB
    Rizzuto, A
    Thompson, K
    Grigg, LE
    Hare, DL
    CIRCULATION, 2004, 109 (20) : E296 - E296
  • [45] Clinical use of drotrecogin alfa (actived): Patients treated in mercury differ from those in PROWESS
    Schmidt, G
    Bates, B
    McCollam, JS
    Steingrub, J
    CRITICAL CARE MEDICINE, 2003, 31 (12) : A116 - A116
  • [46] A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research
    S M Pastores
    A Shaw
    M D Williams
    E Mongan
    M Alicea
    N A Halpern
    Bone Marrow Transplantation, 2005, 36 : 721 - 724
  • [47] A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research
    Pastores, SM
    Shaw, A
    Williams, MD
    Mongan, E
    Alicea, M
    Halpern, N
    BONE MARROW TRANSPLANTATION, 2005, 36 (08) : 721 - 724
  • [48] Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
    R Beale
    F Brunkhorst
    G Martin
    M Williams
    D Nelson
    J Janes
    Critical Care, 11 (Suppl 2):
  • [49] Biomarker Response to Drotrecogin Alfa (Activated) in Children With Severe Sepsis: Results from the RESOLVE Clinical Trial (vol 13, pg 639, 2012)
    Dalton, H. J.
    Carcillo, J. A.
    Woodward, D. B.
    PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (02) : 237 - 237
  • [50] Wet AMD Project: from Clinical Trials to Clinical Practice
    Azzolini, Claudio
    De Crecchio, Giuseppe
    Donati, Simone
    Pece, Alfredo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345